Evidence map›Paper›PMID 34685608›Full record

SynthesisCells2021

Kir4.1 Dysfunction in the Pathophysiology of Depression: A Systematic Review.

Stefania Della Vecchia, Maria Marchese, Filippo Maria Santorelli, Federico Sicca

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. The involvement of KTranslational psychiatry · 2024
    Review
  7. Article
  8. Article
  9. Review
  10. Trehalose Treatment in Zebrafish Model of Lafora Disease.International journal of molecular sciences · 2022
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Stefania Della VecchiaDepartment of Developmental Neuroscience, IRCCS Stella Maris Foundation, Calambrone, 56128 Pisa, Italy.
Maria MarcheseDepartment of Molecular Medicine, IRCCS Stella Maris Foundation, Via dei Giacinti 2, 56128 Pisa, Italy.ORCID 0000-0002-0194-0702
Filippo Maria SantorelliDepartment of Molecular Medicine, IRCCS Stella Maris Foundation, Via dei Giacinti 2, 56128 Pisa, Italy.ORCID 0000-0002-1359-9062
Federico SiccaDepartment of Developmental Neuroscience, IRCCS Stella Maris Foundation, Calambrone, 56128 Pisa, Italy.
Fondazione Stella Maris · ITUniversity of Pisa · IT

Funding

Fondazione Cassa di Risparmio di LuccaItalian Ministry of Health - Ricerca Corrente and 5 × 1000 (to FMS and FS) none
6 · The paper itself

Abstract

A serotonergic dysfunction has been largely postulated as the main cause of depression, mainly due to its effective response to drugs that increase the serotonergic tone, still currently the first therapeutic line in this mood disorder. However, other dysfunctional pathomechanisms are likely involved in the disorder, and this may in part explain why some individuals with depression are resistant to serotonergic therapies. Among these, emerging evidence suggests a role for the astrocytic inward rectifier potassium channel 4.1 (Kir4.1) as an important modulator of neuronal excitability and glutamate metabolism. To discuss the relationship between Kir4.1 dysfunction and depression, a systematic review was performed according to the PRISMA statement. Searches were conducted across PubMed, Scopus, and Web of Science by two independent reviewers. Twelve studies met the inclusion criteria, analyzing Kir4.1 relationships with depression, through in vitro, in vivo, and

Indexed as

Antidepressive AgentsAntidepressive Agents, TricyclicAstrocytesBrain-Derived Neurotrophic FactorDepressionDown-RegulationHumansKcnj10 ChannelKetaminePotassium Channels, Inwardly RectifyingSelective Serotonin Reuptake InhibitorsUp-RegulationAntidepressive AgentsAntidepressive Agents, TricyclicBrain-Derived Neurotrophic FactorKcnj10 ChannelKetaminePotassium Channels, Inwardly RectifyingSelective Serotonin Reuptake InhibitorsastrocytesBDNFdepressionglutamateKir4.1serotonin

Identifiers

PMID34685608
PMCPMC8534194
OpenAlexW3203842739

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.